إعلان
إعلان
GOSS
Gossamer Bio, Inc. Common Stock
2.50
USDبرعاية
0.00
+0.20%
٠٩ يناير, ١٥:٥٨ UTC -5
مغلق
بعد الإغلاق
2.52
+0.02
+0.60%
تقارير أرباح GOSS
النسبة الإيجابية المفاجئة
GOSS تفوق 14 من 28 آخر التقديرات.
50%
التقرير التالي
بيانات التقرير القادم
١١ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$7.67M
/-$0.18
التغير الضمني من Q3 25 (Revenue/ EPS)
-42.28%
/-14.29%
التغير الضمني من Q4 24 (Revenue/ EPS)
-18.19%
/+20.00%
Gossamer Bio, Inc. Common Stock earnings per share and revenue
On ٠٥ نوفمبر ٢٠٢٥, GOSS reported earnings of -0.21 USD per share (EPS) for Q3 25, missing the estimate of -0.19 USD, resulting in a -7.36% surprise. Revenue reached 13.29 مليون, compared to an expected 6.46 مليون, with a 105.88% difference. The market reacted with a -2.53% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 10 المحللين forecast an EPS of -0.18 USD, with revenue projected to reach 7.67 مليون USD, implying an نقصان of -14.29% EPS, and نقصان of -42.28% in Revenue from the last quarter.
الأسئلة الشائعة
What were Gossamer Bio, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Gossamer Bio, Inc. Common Stock reported EPS of -$0.21, missing estimates by -7.36%, and revenue of $13.29M, 105.88% above expectations.
How did the market react to Gossamer Bio, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -2.53%, changed from $2.37 before the earnings release to $2.31 the day after.
When is Gossamer Bio, Inc. Common Stock expected to report next?
The next earning report is scheduled for ١١ مارس ٢٠٢٦.
What are the forecasts for Gossamer Bio, Inc. Common Stock's next earnings report?
Based on 10
المحللين, Gossamer Bio, Inc. Common Stock is expected to report EPS of -$0.18 and revenue of $7.67M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان